Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
human allogeneic adipose-derived mesenchymal adult stem cells
- Development stage
- Unknown
- Lead developer
- Mayo Clinic
- Modality
- Stem Cell Therapies → Cell Therapies
- Administration
- Intratumoral, Intrathecal, Intravenous
01
Overview
Human allogeneic adipose-derived mesenchymal adult stem cells are mesenchymal stem/stromal cells (MSCs) isolated from the adipose (fat) tissue of human donors, expanded in culture, and administered to unrelated patients[2][4][5]. These cells exhibit immunomodulatory, anti-inflammatory, and regenerative properties primarily via paracrine signaling—secreting cytokines, growth factors, and trophic factors that support tissue repair and modulate immune responses[2][3][5]. They are considered for treating a range of conditions including neurological disorders, type 1 and type 2 diabetes, Crohn's disease (particularly for complex perianal fistulas), subcutaneous tissue defects, wound healing, degenerative diseases, and certain cancers like glioblastoma[2][3][4][5]. Therapeutic administration may be via local (intratumoral), intrathecal, or intravenous routes[1][4][5]. Mayo Clinic is a noted developer and sponsor of recent clinical trials[4]. The product is not standardized internationally; its characterization and manufacturing vary, with current studies focused on safety, dose finding, and mechanistic profiling[2][4][5].
- Other names
- allogeneic adipose-derived mesenchymal stem cellsallogeneic AD-MSCsallogenic adipose-derived mesenchymal stromal cellshuman allogeneic adipose-derived mesenchymal adult stem cells
Beyond the preview
Go deeper on human allogeneic adipose-derived mesenchymal adult stem cells.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on human allogeneic adipose-derived mesenchymal adult stem cells.